EMA Looks For Efficiencies For Companies Ahead Of Relaunching Clinical Data Transparency Policy

 
• By Vibha Sharma

Based on its learnings from proactively publishing clinical trial data on COVID-19 products, the European Medicines Agency is making procedural changes to its clinical data publication policy that is set to resume after being temporarily suspended in 2018.

A businessman in formal wear signing a contract. Padlock Hologram icons over the working desk.
Companies must justify the redaction of any commercially confidential information in clinical reports • Source: Shutterstock

More from Europe

More from Geography